CELH has been a big winner, and the Pepsi deal helped with investor confidence to keep its run going. We still like it, for sure, but it is expensive, and it is certainly not risk free. We can't comment on position sizes but 11% is high for any stock. We like LMN a lot, and consider it a sleeper, slow-and-steady type of stock. Most of its growth is going to come from acquisitions, unlike CELH which is marketing and building market share. LMN will likely prove far less 'exciting' than CELH has in the past three years, but boring can be good too. We would be fine with a switch of some in order to reduce single company risk and diversify. LMN has a US OTC listing, under symbol LMGIF. Trading liquidity is very weak, however, and we would use caution and never use market orders on this exchange.
Authors of this answer, directors, partners and/or officers of 5i Research and/or affiliated companies have a financial or other interest in PEP, CELH.